News
The executive order instructs the FDA to expedite the approval process for domestic pharmaceutical manufacturing facilities.
The FDA approved 19 biosimilars in 2024, a sharp jump from the five greenlit by the agency in 2023. 2024 saw the highest ...
Artificial Intelligence (AI) is now used throughout clinical trials, from recruitment to analysis – but are regulators ...
AGC Biologics has collaborated with Quell Therapeutics to advance the development of several T-regulatory (Treg) cell therapy ...
Pathos AI has raised $365m in a Series D funding round to widen its AI-enabled platform to advance the development of ...
The FDA has approved MSD’s Welireg for rare adrenal tumours, and AbbVie’s Emrelis for treating c-Met+ lung cancer patients.
From predictive analytics to robotic warehousing, automation is unlocking new efficiencies in pharma logistics.
As pressure to comply with stringent environmental regulations mounts, could green chemistry strategies provide the solution?
Isolator lines play a crucial role in the pharmaceutical industry by providing a sterile environment for drug products while protecting operators from exposure to hazardous substances. They also ...
AbbVie has signed a collaboration and licensing agreement with US-based ADARx Pharmaceuticals, committing $335m upfront to ...
Pharmaceutical Technology Excellence Awards are now open for submissions, and you can download our Research Guide for more ...
The French drugmaker said it would commit at least $20bn in the US through 2030, with the aim to increase R&D and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results